CCI study looks at risks for patients with diabetes treated with PCI

09/23/2013 | Healio

Diabetes patients who underwent PCI for STEMI had nearly four times the mortality rate of patients who did not have diabetes, according to results from the INFUSE-AMI trial published in Catheterization and Cardiovascular Interventions. Study participants with diabetes had more extensive left anterior descending artery disease, more comorbidities and a 30-day mortality rate of 8.1%, compared with 2.3% among the group without diabetes. The 30-day revascularization rate was 6.4% for diabetes patients compared with 1% for non-diabetes patients.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA